Oncologie takes in $80 mln Series B
Boston and Shanghai-based Oncologie, an biopharmaceutical company, has secured $80 million in Series B financing. Nan Fung Life Sciences and Pivotal BioVentures China led the round.
11 June 2019•1 min read
Boston and Shanghai-based Oncologie, an biopharmaceutical company, has secured $80 million in Series B financing. Nan Fung Life Sciences and Pivotal BioVentures China led the round.
